[1]
Abbas, S.H. et al. 2017. POTENTIAL BENEFIT OF CURCUMIN ADJUVANT THERAPY TO THE STANDARD H. PYLORI ERADICATION THERAPY IN PATIENTS WITH PEPTIC ULCER DISEASE. Asian Journal of Pharmaceutical and Clinical Research. 10, 5 (May 2017), 313–317. DOI:https://doi.org/10.22159/ajpcr.2017.v10i5.17462.